Terumo Cardiovascular

Last Chance to Register: Join us for a live educational webinar and earn free CEU credits. https://lnkd.in/gNd3xsBR Under the guidance of Terumo Cardiovascular Clinical Specialists, attendees will learn about the latest evidence supporting the importance of a comprehensive Goal Directed Perfusion program. Registrants will gain a more complete understanding of how GDP strategies can impact patient outcomes and healthcare economics. Attendees will also be introduced to the latest FDA cleared advances in continuous patient monitoring platforms. Register Now: https://lnkd.in/gNd3xsBR #perfusion

Today marks a special moment for all of Terumo as we celebrate the introduction of the new 1,000 yen bank note in Japan featuring one of Terumo's founders Dr. Shibasaburo Kitasato. #Terumo #ContributingtoSociety

Join us for a live educational webinar and earn free CEU credits: https://lnkd.in/gFRaUuzw Under the guidance of Terumo Cardiovascular Clinical Specialists, attendees will learn about the latest evidence supporting the importance of a comprehensive Goal Directed Perfusion program. Registrants will gain a more complete understanding of how GDP strategies can impact patient outcomes and healthcare economics. Attendees will also be introduced to the latest FDA cleared advances in continuous patient monitoring platforms. Register Now: https://lnkd.in/gFRaUuzw #perfusion

📢Dr. Shibasaburo Kitasato was chosen as the portrait of the new 1,000 yen note!! A #Terumo ’s history of Contributing to Society through Healthcare. In 1921, Terumo was founded by a group of physicians and scientists, including Dr. Shibasaburo Kitasato, to produce clinical thermometers in Japan after imports ceased due to war. Since then, we have been supporting the foundation of healthcare in Japan and have been advancing alongside the evolution of healthcare. ✅ The 1960s, contributed to infection control in medical settings ✅ The 1970s, promoted global expansion ✅ The 1980s, entered the fields of cardiac surgery and vascular intervention, subsequently branched out further into products supporting minimally invasive procedures ✅ The 1990s, a leading-edge medical device manufacturer joined the Terumo Group, accelerating globalization ✅ The 2000s, pursuing solutions to issues and challenges in the medical field Terumo will continue to pursue innovation to create new value in the next generation of healthcare. https://lnkd.in/gXxysdzW

Japan’s redesigned bank notes will be issued on July 3, 2024. Dr. Shibasaburo Kitasato, one of the founders of Terumo Corporation, has been chosen as the portrait of the new 1,000 yen note. He is a renowned medical scientist known as the "Father of Modern Medicine in Japan" for his achievements. He successfully cultivated the tetanus bacterium for the first time in the world in 1889 and discovered the tetanus antitoxin the following year. Terumo was founded in 1921 by a group of physicians and scientists, including Dr. Shibasaburo Kitasato, to meet the desperate need for production of quality thermometers in Japan. These words appeared in the founding prospectus: ❝As the health of the people of Japan depends on the spread of hygiene awareness, and as the health of the people is the key to national stability, this can be called an industry of national concern❞ The founder’s mindset lives on in the Terumo Group Mission: Contributing to Society through Healthcare. Terumo will continue to challenge the advancement of healthcare and the enhancement of patients' quality of life. Photograph courtesy of The Kitasato Institute Kitasato Shibasaburo Memorial Museum

Juneteenth is a time to reflect on our shared history and renew our commitment to building a more equitable future. At Terumo Cardiovascular, we firmly believe in fostering an inclusive and diverse work environment through our Core Value of Respect – Appreciative of others, and by valuing and celebrating every individual’s unique experiences and heritage. 

Terumo’s next perfusion innovation is here – the CDI OneView Monitoring System. Driven by continuous in-line monitoring technology, Terumo’s new CDI OneView System displays multiple Goal Directed Perfusion parameters, enabling real-time insight and decision making. Learn more about the benefits of the CDI OneView System: https://lnkd.in/gJTXrRq5 #Perfusion

Terumo Aims for Digital Transformation in Healthcare To Prepare for major changes in the medical environment Terumo aims to explore a new direction in it while focusing on the frontline of healthcare. Specifically, by leveraging Terumo’s unique strengths we will make a major shift to creating unique solutions that address the concerns in the medical field and the ones raised among patients. - We offer a wide variety of products and services as a medical device manufacturer - Our DX Promotion Department promotes both “DX for business creation” and “Operational DX” By combining these two strengths with rapidly developing advanced technologies, we will create new healthcare values and actively promote DX in healthcare. For more information, please click here. https://lnkd.in/eBvxKcc4

At the recent #SanibelSymposium, Terumo Clinical Support Specialist Carol Ann Rosenberg BA MBA CCP, explored perfusion best practices while presenting, “Current Research and the Latest Monitoring Technology.”   “We cannot underestimate the crucial role perfusionist play in optimizing patient outcomes, especially in managing comorbidities like acute kidney injury. We are working together with perfusionists to share the latest research, techniques and technology that will help accelerate advancements in quality, personalized patient care."   The next innovation in patient monitoring may be closer than you think. Sign up now to be among the first to know what’s new from Terumo Cardiovascular: https://lnkd.in/eHR2Gwcb #Perfusion

We're hiring! Read about our latest job opening here: Sr. FP&A Cash Analyst - Hybrid - https://bit.ly/4aoVF0J #AnnArborJobs #medicaldevices